Your Health, We Care
Release date: 2026-03-31 17:13:21 Article From: Lucius Laos Recommended: 6
All medications may be associated with certain adverse reactions, and asciminib is no exception. Most reactions are mild to moderate and manageable, but severe adverse events requiring clinical intervention may occur in individual cases.
Seek immediate medical attention if you experience any of the following side effects while taking asciminib:
Hematologic and Coagulation System: Black, tarry stools; bleeding gums; blood in urine or stools; unusual bleeding or bruising; pinpoint red spots on skin; pale skin.
Cardiovascular System: Chest pain or tightness; distended neck veins; irregular heartbeat; slow or fast heartbeat.
Respiratory and Throat: Cough; difficulty breathing; sneezing; sore throat; stuffy or runny nose; hoarseness; loss of voice; difficulty swallowing.
Nervous System: Dizziness; headache; nervousness; fainting.
Skin and Mucous Membranes: Hives; itching; rash; skin redness; swelling of eyelids, face, lips, hands, or feet; ulcers, sores, or white spots in the mouth; irritation.
Musculoskeletal System: Body aches or pain; joint pain, stiffness, or swelling.
Genitourinary System: Decreased urine output; lower back or side pain; painful or difficult urination.
Bladder pain; bloating; blood in urine or cloudy urine; burning sensation during urination; coughing up blood; frequent urination; increased menstrual flow or vaginal bleeding; indigestion; nosebleeds; pain in chest, groin, or legs (especially calves); pain in abdomen or side (may radiate to back); paralysis; prolonged bleeding from cuts; sudden severe headache; sudden loss of coordination; sudden slurred speech; sudden vision changes; vomiting; yellowing of eyes or skin.
Consult your healthcare provider if any of the following side effects persist, are bothersome, or if you have questions about them:
Diarrhea; difficulty moving; muscle or bone pain; muscle stiffness; joint pain; stomach pain.
Constipation.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：2072025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4432024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：2132025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：2312025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：2072025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2362025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：2212025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：2042025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
